These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19860926)

  • 1. What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.
    Kinyanjui SM; Bejon P; Osier FH; Bull PC; Marsh K
    Malar J; 2009 Oct; 8():242. PubMed ID: 19860926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.
    Marsh K; Otoo L; Hayes RJ; Carson DC; Greenwood BM
    Trans R Soc Trop Med Hyg; 1989; 83(3):293-303. PubMed ID: 2694458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
    Lynch MM; Cernetich-Ott A; Weidanz WP; Burns JM
    Clin Vaccine Immunol; 2009 Mar; 16(3):293-302. PubMed ID: 19116303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between circulating S-antigens, naturally acquired antibodies to Plasmodium falciparum exoantigens and malaria attack in a mesoendemic area.
    Chumpitazi BF; Peyron F; Boudin C; Picot S; Oury B; Ambroise-Thomas P
    Acta Trop; 1992 Apr; 50(4):295-304. PubMed ID: 1356300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.
    McCallum FJ; Persson KE; Fowkes FJ; Reiling L; Mugyenyi CK; Richards JS; Simpson JA; Williams TN; Gilson PR; Hodder AN; Sanders PR; Anders RF; Narum DL; Chitnis C; Crabb BS; Marsh K; Beeson JG
    J Leukoc Biol; 2017 Apr; 101(4):913-925. PubMed ID: 27837017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants.
    Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP
    Malar J; 2019 Jan; 18(1):19. PubMed ID: 30670032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Repertoire of Human Antibodies Against
    Kanoi BN; Nagaoka H; White MT; Morita M; Palacpac NMQ; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T; Takashima E
    Front Immunol; 2020; 11():893. PubMed ID: 32477363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.
    Kusi KA; Manu EA; Manful Gwira T; Kyei-Baafour E; Dickson EK; Amponsah JA; Remarque EJ; Faber BW; Kocken CHM; Dodoo D; Gyan BA; Awandare GA; Atuguba F; Oduro AR; Koram KA
    PLoS One; 2017; 12(9):e0185303. PubMed ID: 28945794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
    Kinyanjui SM; Mwangi T; Bull PC; Newbold CI; Marsh K
    J Infect Dis; 2004 Nov; 190(9):1527-33. PubMed ID: 15478055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis.
    Obiero JM; Campo JJ; Scholzen A; Randall A; Bijker EM; Roestenberg M; Hermsen CC; Teng A; Jain A; Davies DH; Sauerwein RW; Felgner PL
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30787114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens.
    Amoani B; Gyan B; Sakyi SA; Abu EK; Nuvor SV; Barnes P; Sarkodie-Addo T; Ahenkorah B; Sewor C; Dwomoh D; Theisen M; Cappello M; Wilson MD; Adu B
    BMC Infect Dis; 2021 Apr; 21(1):332. PubMed ID: 33832450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe.
    Kobayashi T; Jain A; Liang L; Obiero JM; Hamapumbu H; Stevenson JC; Thuma PE; Lupiya J; Chaponda M; Mulenga M; Mamini E; Mharakurwa S; Gwanzura L; Munyati S; Mutambu S; Felgner P; Davies DH; Moss WJ
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30918058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines.
    Mendis KN; David PH; Carter R
    Int J Parasitol; 1990 Jul; 20(4):497-502. PubMed ID: 2210943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acquisition of long-lived memory B cell responses to merozoite surface protein-8 in individuals with Plasmodium vivax infection.
    Kochayoo P; Kittisenachai N; Changrob S; Wangriatisak K; Muh F; Chootong P; Han ET
    Malar J; 2019 May; 18(1):188. PubMed ID: 31151441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens.
    Riley EM
    Parasitology; 1996; 112 Suppl():S39-51. PubMed ID: 8684835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of Malian children from clinical malaria is associated with recognition of multiple antigens.
    Daou M; Kouriba B; Ouédraogo N; Diarra I; Arama C; Keita Y; Sissoko S; Ouologuem B; Arama S; Bousema T; Doumbo OK; Sauerwein RW; Scholzen A
    Malar J; 2015 Feb; 14():56. PubMed ID: 25653026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PfEMP1 as a target of human immunity and a vaccine candidate against malaria.
    Beeson JG; Chan JA; Fowkes FJ
    Expert Rev Vaccines; 2013 Feb; 12(2):105-8. PubMed ID: 23414401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.